Released: 9-Sep-2016 8:05 AM EDT
Biomarker-Based Test Delivers Precision Medicine to Children with Complex Neuropsychiatric Illnesses
Moleculera Labs, Inc.

Researchers from the University of Oklahoma Health Sciences Center, in collaboration with the National Institute of Mental Health, have developed the first-of-its-kind biomarker test to help identify autoimmune-induced neuropsychiatric disorders.